VICP · Vicapsys Life Sciences, Inc.
Market Cap
$32.37M
Shares
32.37M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Net Income
-$1.18M
-20%
FY2023
Diluted EPS
-$0.03
0%
FY2023
Operating Cash Flow
-$417.52K
-75.3%
FY2023
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| $14.09K | $15.27K | $13.1K | $17.7K | $102.18K | $98.98K | |
| $92.25K | $96.43K | $60.2K | $35.79K | $46.96K | $54.11K | |
| — | $0 | $31.29K | $31.33K | — | — | |
| $1.11M | $1.05M | $984.79K | $336.87K | $765.84K | $1.03M | |
| -$1.11M | -$1.05M | -$984.79K | -$336.87K | -$765.84K | — | |
| — | $19.97K | — | — | — | — | |
| — | -$135.13K | — | $100K | — | — | |
| — | — | — | $100K | — | — | |
| -$1.35M | -$1.18M | -$984.79K | -$236.87K | -$765.84K | -$1.03M | |
| -$1.35M | -$1.18M | -$984.79K | -$236.87K | -$765.84K | -$1.41M | |
| — | -$1.18M | -$988.34K | -$236.87K | -$765.84K | -$1.57M | |
| USD/shares | -$0.04 | -$0.03 | -$0.03 | -$0.01 | — | — |
| USD/shares | -$0.04 | -$0.03 | -$0.03 | — | — | — |
| shares | — | 34.55M | 30.58M | 17.66M | 17.48M | 11.4M |
| shares | — | 34.55M | 30.58M | 17.66M | 17.48M | 11.4M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Coverage backlog: 23 eligible filings and 0 covenant artifacts have no current-version terminal extraction result. This includes untouched sources and sources on the retry ladder.
No terminal debt extraction result is available yet; this is not evidence that the company has no debt.